Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma

Clinical trial NCT01598038 · TERMINATED

Trial details

NCT number: NCT01598038
Sponsor: Centre Francois Baclesse
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2012-04-01
Primary completion: 2015-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.